Find Ibopamine manufacturers, exporters & distributors on PharmaCompass

Ibopamine

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 Europe

2 FDF Dossiers
2 Europe

GLOBAL SALES INFORMATION

2 Finished Drug Prices

globalSalesInformation
2 Finished Drug Prices

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 66195-31-1, Sb 7505, 4-(2-(methylamino)ethyl)-o-phenylene diisobutyrate, 8zca2i2l11, Propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester, Sb-7505

Molecular Formula

C₁₇H₂₅NO₄

Molecular Weight

307.4 g/mol

InChI Key

WDKXLLJDNUBYCY-UHFFFAOYSA-N

FDA UNII

8ZCA2I2L11

ibopamine is a natural product found in Melodinus fusiformis with data available.

1 2D Structure

Ibopamine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate

2.1.2 InChI

InChI=1S/C17H25NO4/c1-11(2)16(19)21-14-7-6-13(8-9-18-5)10-15(14)22-17(20)12(3)4/h6-7,10-12,18H,8-9H2,1-5H3

2.1.3 InChI Key

WDKXLLJDNUBYCY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C

2.2 Other Identifiers

2.2.1 UNII

8ZCA2I2L11

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Escandine

2. Ibopamine Hydrochloride

3. Inopamil

4. N-methyldopamine Diisobutyrate

5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester

6. Sb 7505

7. Sb-7505

2.3.2 Depositor-Supplied Synonyms

1. 66195-31-1

2. Sb 7505

3. 4-(2-(methylamino)ethyl)-o-phenylene Diisobutyrate

4. 8zca2i2l11

5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester

6. Sb-7505

7. Ibopamino [inn-spanish]

8. Sb 7505; Sb 7505 (pharmaceutical); Skf 100168

9. Ibopaminum

10. Ibopamino

11. 4-(2-(methylamino)ethyl)-1,2-phenylene Bis(2-methylpropanoate)

12. Ibopaminum [inn-latin]

13. Einecs 266-229-5

14. Skf 100168

15. Unii-8zca2i2l11

16. Ibopamine [usan:inn:ban]

17. Trazyl

18. 4-(2-(methylamino)ethyl)-2-phenylendiisobutyrat

19. Ibopamine [inn]

20. Ibopamine [mi]

21. Ibopamine (usan/inn)

22. Ibopamine [usan]

23. Ibopamine [mart.]

24. [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate

25. Ibopamine [who-dd]

26. Schembl147258

27. Chembl307739

28. Dtxsid3023138

29. Chebi:135306

30. Zinc1542906

31. Db13316

32. D04488

33. L013392

34. Q5984366

35. 4-[2-(methylamino)ethyl]benzene-1,2-diyl Bis(2-methylpropanoate)

36. 5-[2-(methylamino)ethyl]-2-[(2-methylpropanoyl)oxy]phenyl 2-methylpropanoate

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₂₅NO₄
Molecular Weight	307.4 g/mol
XLogP3	2.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	9
Exact Mass	307.17835828 g/mol
Monoisotopic Mass	307.17835828 g/mol
Topological Polar Surface Area	64.6 Å²
Heavy Atom Count	22
Formal Charge	0
Complexity	368
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)

Dopamine Agonists

Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

Diuretics

Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)

Mydriatics

Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)

4.2 ATC Code

C - Cardiovascular system

C01 - Cardiac therapy

C01C - Cardiac stimulants excl. cardiac glycosides